Sonneveld P, Richardson PG, Ludwig H, Dimopoulos M-A, Schjesvold FH, Hajek R, Abdulhaq H, Thuresson M, Norin S, Bakker NA, et al. Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies. Clin Lymphoma Myeloma Leuk. 2023.